These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10469788)

  • 1. Joint statement of the American Academy of Pediatrics (AAP) and the United States Public Health Service (USPHS).
    Pediatrics; 1999 Sep; 104(3 Pt 1):568-9. PubMed ID: 10469788
    [No Abstract]   [Full Text] [Related]  

  • 2. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Ann Pharmacother; 1999 Sep; 33(9):1021. PubMed ID: 10492513
    [No Abstract]   [Full Text] [Related]  

  • 3. Thimerosal in vaccines--An interim report to clinicians. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Environmental Health.
    Pediatrics; 1999 Sep; 104(3 Pt 1):570-4. PubMed ID: 10469789
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Neonatal Netw; 1999 Sep; 18(6):65, 72. PubMed ID: 10690100
    [No Abstract]   [Full Text] [Related]  

  • 6. Summary of the joint statement on thimerosal in vaccines. American Academy of Family Physicians, American Academy of Pediatrics, Advisory Committee on Immunization Practices, Public Health Service.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jul; 49(27):622, 631. PubMed ID: 10914930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations regarding the use of vaccines that contain thimerosal as a preservative.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Nov; 48(43):996-8. PubMed ID: 10577494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thimerosal and vaccines--a cautionary tale.
    Offit PA
    N Engl J Med; 2007 Sep; 357(13):1278-9. PubMed ID: 17898096
    [No Abstract]   [Full Text] [Related]  

  • 10. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(26):563-5. PubMed ID: 10418806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing risks and benefits: Primum non nocere is too simplistic.
    Halsey NA; Goldman L
    Pediatrics; 2001 Aug; 108(2):466-7. PubMed ID: 11483816
    [No Abstract]   [Full Text] [Related]  

  • 12. Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
    Halsey NA
    JAMA; 1999 Nov; 282(18):1763-6. PubMed ID: 10568650
    [No Abstract]   [Full Text] [Related]  

  • 13. From the Centers for Disease Control and Prevention. Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices. American Academy of Pediatrics/U.S. Public Health Service.
    JAMA; 2001 Mar; 285(12):1568-70. PubMed ID: 11302135
    [No Abstract]   [Full Text] [Related]  

  • 14. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety of thimerosal containing vaccines. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society].
    Muñoz M A; Abarca V K; Jiménez de la J J; Luchslnger F V; O'Ryan G M; Ripoll M E; Valenzuela B MT; Vergara F R
    Rev Chilena Infectol; 2007 Oct; 24(5):372-6. PubMed ID: 17989841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of thimerosal from vaccines set as goal.
    Miller JL
    Am J Health Syst Pharm; 1999 Aug; 56(16):1589, 1593. PubMed ID: 10459378
    [No Abstract]   [Full Text] [Related]  

  • 17. Does thimerosal or other mercury exposure increase the risk for autism? A review of current literature.
    Schultz ST
    Acta Neurobiol Exp (Wars); 2010; 70(2):187-95. PubMed ID: 20628442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What happened to primum non nocere?
    Seal JB; Daum RS
    Pediatrics; 2001 May; 107(5):1177-8. PubMed ID: 11331704
    [No Abstract]   [Full Text] [Related]  

  • 19. Mercury, vaccines, and autism, revisited.
    Silbergeld EK
    Am J Public Health; 2008 Aug; 98(8):1350; author reply 1350-1. PubMed ID: 18556596
    [No Abstract]   [Full Text] [Related]  

  • 20. Thiomersal in vaccines: is removal warranted?
    Clements CJ; Ball LK; Ball R; Pratt RD
    Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.